Jubilant Pharma Ltd, a subsidiary of India-based pharmaceutical firm Jubilant Life Sciences (NSE: JUBILANT), has received final approval from the US health regulator for Bupropion
Hydrochloride Extended-Release Tablets, a BSE filing by the company revealed on Thursday.
Sun Pharma (NSE: SUNPHARMA), an Indian multinational pharmaceutical company, has issued a voluntary recall of an anti-depressant drug known as Bupropion
Hydrochloride, it emerged on Wednesday.
and varenicline have been tied to long-term smoking cessation in observational studies and randomized trials.
Our findings suggest that smokers trying to quit will have a better experience with varenicline as opposed to trying to quit on their own or by taking bupropion
is the only Food and Drug Administration (FDA)-approved antidepressant recommended as a first-line pharmacologic agent to assist with smoking cessation, based in part on a meta-analysis of 44 placebo-controlled RCTs (13,728 patients), which found that bupropion
had a relative risk (RR) of 1.
A total of 19 of the randomized clinical trials assessed nicotine replacement therapy against placebo, 27 assessed bupropion
against placebo, 18 assessed varenidine against placebo, 1 assessed high-dose nicotine replacement therapy against placebo, 1 assessed combination nicotine replacement therapy against a control condition, 2 assessed bupropion
against varenicline, 3 assessed bupropion
against nicotine replacement therapy, and 1 assessed varenicline against nicotine replacement therapy.
After a 6-week period of bupropion
treatment, craving for Internet video game play, total game play time, and cue-induced brain activity in dorsolateral prefrontal cortex was decreased.
Washington, Mar 23 ( ANI ): Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline compared to bupropion
and to placebo - unmedicated assisted smoking cessation -according to a new study.
One of the generic forms of the 300-mg dose of extended-release bupropion
is being taken off the market because of evidence indicating that it is not therapeutically equivalent to the brand name version of the antidepressant, according to a Food and Drug Administration notice report posted on Oct.
Separately, Wockhardt has received final approval from the FDA for marketing 100 mg, 150 mg and 200 mg 12-hour extended-release tablets of Bupropion
HCI, which is used in the treatment of depression.
Wockhardt announced that it has secured final approval from the US FDA for marketing 100 mg, 150 mg and 200 mg 12-hour extended release tablets of Bupropion
HCl which is used in the treatment of depression.
In the recent decade, researchers have expressed renewed interest in therapeutic effects of bupropion
an atypical antidepressant and smoking cessation aid on these symptoms.
In the past, bupropion
(Wellbutrin) was a Pregnancy Category B drug and remained so long after the serotonin reuptake inhibitors (SRIs) were changed to Pregnancy Category C (Category D in the case of paroxetine [Paxil]).
The author recommends use of bupropion
during inpatient detoxification and continuing after discharge.
Participants were randomly prescribed either a combination of the drugs naltrexone and bupropion
or "dummy" placebo pills.